Ubs Group Ag INHIBIKASE THERAPEUTICS INC Transaction History

Ubs Group Ag

  • $611 Billion
  • Q3 2025
Number of Shares
136,280
Previous 38,674 252.38%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
N/A
97,606 Added 252.38%
136,280 $0
Q2 2025

Aug 14, 2025
SELL
N/A
-6,592 Reduced 14.56%
38,674 $0
Q1 2025

May 13, 2025
BUY
N/A
17,740 Added 64.45%
45,266 $0
Q4 2024

Feb 14, 2025
BUY
N/A
22,653 Added 464.87%
27,526 $0
Q3 2024

Nov 14, 2024
BUY
N/A
4,873 New
4,873 $0
Q1 2024

May 13, 2024
BUY
N/A
3,214 New
3,214 $0
Q3 2023

Nov 09, 2023
BUY
N/A
149 New
149 $0
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email